Company profile
Cievert Ltd
Cievert Ltd is a UK company with status active founded in 2011.
Corporate ownership
Updated 06 Jun 2026 16:52
Company events
Reference milestones and recent Companies House filing stream events.
Accounts due
Accounts DueNext accounts due date
Confirmation statement due
Confirmation DueNext confirmation statement due date
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Accounts filed
AccountsLast accounts made up date
Incorporated
InceptionCompany registered at Companies House
Public funding
Projects
Predicting kidney and liver damage in cancer patients receiving chemotherapy
1 Aug 2022 to 31 Jul 2024
Chemotherapy is the treatment of disease using chemical substances, commonly used to treat cancer. Chemotherapy is often cytotoxic and two common risks relate to kidney and liver damage. Affected patients may require delays or changes to treatment and even treatment suspension. Whilst only <10% of patients will encounter kidney and/or liver damage, curren...
University of Durham and Cievert Limited
1 Sep 2019 to 28 Feb 2022
To enhance the management of outpatient follow-up by improved identification and treatment of radiotherapy side effects using machine learning and artificial intelligence.
Developing Artificial Intelligence to revolutionise how radiotherapy patients are managed whilst receiving treatment
1 Feb 2018 to 31 Jan 2019
"Cievert is a digital health SME specialising in designing and implementing innovative software in the health sector. Established in 2011 by a former NHS radiographer, Cievert software can now be found in 20% of all NHS cancer centres. In England alone, there are 100million NHS outpatient appointments every year\*. These cost an estimated £10billion, requ...